. The real prevalence of this form remained unknown for many years and was only an occasional post-mortem report, chiefly in middle-aged and elderly women (Goudie et al. 1959; Williams & Doniach 1962) .
Following the introduction of autoantibody screening, TA were found in 6 -9% of the general population (Tunbridge et al. 1977; Barbato et al. 1980; Hawkins et al. 1980; Amino et al. 1980) , in 6-18% of selected hospital patients (Hacken et al. 1960; Hill 1961; Bastenie et al. 1967) , and in 13-31% of patients with organ-specific autoim¬ mune diseases without any clinical thyroid dis¬ order (Bundey et al. 1972; Betterle et al. 1984) . Several studies of normal populations (Tunbridge et al. 1977; Hawkins et al. 1980 ) and of subjects with insulin-dependent diabetes mellitus (IDDM) (Riley et al. 1982; Betterle et al. 1984) (Hamilton et al. 1978) . Fiducial limits of predictions are given when > 120.
Results
Immunological study Table 1 summarizes the prevalence of thyroid autoantibodies in the different groups studied, fn the normal population we found that 12% of the females and 1% of the males were seropositive. In all the other groups there was an increased pre¬ valence of seropositivity with respect to that found in the normal population, but a statistically signi¬ ficant increased prevalence was found only in patients with diabetes mellitus (P < 0.001), vitíligo ( < 0.05), alopecia areata (P < 0.05) and in males with hypoparathyroidism (P < 0.001). The overall female/male ratio of seropositive subjects was 3 to 1. In these seropositive subjects 347 (85%) had only TMA, 8 (2%) had only TgHA, whereas 53 (13%) had both TMA and TgHA. months (mean ± SD: 24 ± 10 months).
In the group of 90 subjects with initially normal (Gorsuch et al. 1981; Betterle et al. 1982 Betterle et al. , 1983 (1981) and Gordin & Lamberg (1981) ; whereas these authors found that the risk of developing overt hypothyroidism was present only in seropositive subjects with high basal TSH levels and not in those with normal levels, our study revealed that 31% of the subjects followed showed progressive worsening of SAT grade, and thus we may consider subjects with normal basal TSH levels and thyroid autoanti¬ bodies to be at risk for thyroid impairment. Over¬ all, 78 seropositive subjects (39%) had, or after¬ wards developed, a silent functional thyroid dis¬ order (i.e. about 2-6% of the population studied).
A high incidence of coronary heart disease in patients with subclinical hypothyroidism has been described (Bastenie et 
